Earth Science Tech Past Earnings Performance
Past criteria checks 5/6
Earth Science Tech has been growing earnings at an average annual rate of 47.6%, while the Pharmaceuticals industry saw earnings growing at 1.2% annually. Revenues have been growing at an average rate of 89.5% per year. Earth Science Tech's return on equity is 72.8%, and it has net margins of 8.7%.
Key information
47.6%
Earnings growth rate
45.1%
EPS growth rate
| Pharmaceuticals Industry Growth | 6.0% |
| Revenue growth rate | 89.5% |
| Return on equity | 72.8% |
| Net Margin | 8.7% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Earth Science Tech makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 27 | 2 | 16 | 0 |
| 30 Jun 24 | 20 | 2 | 11 | 0 |
| 31 Mar 24 | 12 | 1 | 6 | 0 |
| 31 Dec 23 | 6 | 0 | 4 | 0 |
| 30 Sep 23 | 2 | 0 | 2 | 0 |
| 30 Jun 23 | 0 | 0 | 1 | 0 |
| 31 Mar 23 | 0 | 0 | 1 | 0 |
| 31 Dec 22 | 0 | 0 | 0 | 0 |
| 30 Sep 22 | 0 | 0 | 0 | 0 |
| 30 Jun 22 | 0 | 3 | 0 | 0 |
| 31 Mar 22 | 0 | 3 | 0 | 0 |
| 31 Dec 21 | 0 | 3 | 0 | 0 |
| 30 Sep 21 | 0 | 3 | 0 | 0 |
| 30 Jun 21 | 0 | -1 | 0 | 0 |
| 31 Mar 21 | 0 | -4 | 0 | 0 |
| 31 Dec 20 | 0 | -4 | 1 | 0 |
| 30 Sep 20 | 0 | -4 | 1 | 0 |
| 30 Jun 20 | 0 | -5 | 1 | 0 |
| 31 Mar 20 | 1 | -1 | 1 | 0 |
| 31 Dec 19 | 1 | -2 | 1 | 0 |
| 30 Sep 19 | 1 | -2 | 1 | 0 |
| 30 Jun 19 | 1 | -2 | 2 | 0 |
| 31 Mar 19 | 1 | -2 | 2 | 0 |
| 31 Dec 18 | 1 | -2 | 2 | 0 |
| 30 Sep 18 | 1 | -2 | 2 | 0 |
| 30 Jun 18 | 1 | -2 | 2 | 0 |
| 31 Mar 18 | 0 | -2 | 2 | 0 |
| 31 Dec 17 | 0 | -2 | 2 | 0 |
| 31 Mar 17 | 0 | -1 | 1 | 0 |
| 31 Dec 16 | 0 | 0 | 1 | 0 |
| 31 Mar 16 | 0 | -1 | 1 | 0 |
| 31 Dec 15 | 0 | -2 | 1 | 0 |
| 30 Sep 15 | 0 | -9 | 9 | 0 |
| 30 Jun 15 | 0 | -9 | 9 | 0 |
| 31 Mar 15 | 0 | -9 | 9 | 0 |
| 31 Dec 14 | 0 | -21 | 21 | 0 |
| 30 Sep 14 | 0 | -13 | 13 | 0 |
| 30 Jun 14 | 0 | -13 | 13 | 0 |
| 31 Mar 14 | 0 | -13 | 13 | 0 |
| 31 Dec 13 | 0 | 0 | 0 | 0 |
Quality Earnings: ETST has high quality earnings.
Growing Profit Margin: ETST's current net profit margins (8.7%) are lower than last year (10%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: ETST has become profitable over the past 5 years, growing earnings by 47.6% per year.
Accelerating Growth: ETST's earnings growth over the past year (957.2%) exceeds its 5-year average (47.6% per year).
Earnings vs Industry: ETST earnings growth over the past year (957.2%) exceeded the Pharmaceuticals industry 54.6%.
Return on Equity
High ROE: ETST's Return on Equity (72.8%) is considered outstanding.